Yoshida M - Search Results

1

Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase.

Dion LD, Goldsmith KT, Tang DC, Engler JA, Yoshida M, Garver RI Jr. Dion LD, et al. Among authors: yoshida m. Virology. 1997 May 12;231(2):201-9. doi: 10.1006/viro.1997.8538. Virology. 1997. PMID: 9168882

2

[Assay for inhibitory activity of histone deacetylase].

Yoshida M. Yoshida M. Gan To Kagaku Ryoho. 2004 Apr;31(4):507-11. Gan To Kagaku Ryoho. 2004. PMID: 15114691 Japanese.

3

From discovery to the coming generation of histone deacetylase inhibitors.

Yoshida M, Matsuyama A, Komatsu Y, Nishino N. Yoshida M, et al. Curr Med Chem. 2003 Nov;10(22):2351-8. doi: 10.2174/0929867033456602. Curr Med Chem. 2003. PMID: 14529478 Review.

4

Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts.

Rombouts K, Niki T, Greenwel P, Vandermonde A, Wielant A, Hellemans K, De Bleser P, Yoshida M, Schuppan D, Rojkind M, Geerts A. Rombouts K, et al. Among authors: yoshida m. Exp Cell Res. 2002 Aug 15;278(2):184-97. doi: 10.1006/excr.2002.5577. Exp Cell Res. 2002. PMID: 12169274

5

Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter.

Westendorf JJ, Zaidi SK, Cascino JE, Kahler R, van Wijnen AJ, Lian JB, Yoshida M, Stein GS, Li X. Westendorf JJ, et al. Among authors: yoshida m. Mol Cell Biol. 2002 Nov;22(22):7982-92. doi: 10.1128/mcb.22.22.7982-7992.2002. Mol Cell Biol. 2002. PMID: 12391164 Free PMC article.

6

Inhibition of histone deacetylase causes reduction of appressorium formation in the rice blast fungus Magnaporthe oryzae.

Izawa M, Takekawa O, Arie T, Teraoka T, Yoshida M, Kimura M, Kamakura T. Izawa M, et al. Among authors: yoshida m. J Gen Appl Microbiol. 2009 Dec;55(6):489-98. doi: 10.2323/jgam.55.489. J Gen Appl Microbiol. 2009. PMID: 20118613

7

Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.

Lee S, Shinji C, Ogura K, Shimizu M, Maeda S, Sato M, Yoshida M, Hashimoto Y, Miyachi H. Lee S, et al. Among authors: yoshida m. Bioorg Med Chem Lett. 2007 Sep 1;17(17):4895-900. doi: 10.1016/j.bmcl.2007.06.038. Epub 2007 Jun 13. Bioorg Med Chem Lett. 2007. PMID: 17588744

8

Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression.

Inoue K, Kobayashi M, Yano K, Miura M, Izumi A, Mataki C, Doi T, Hamakubo T, Reid PC, Hume DA, Yoshida M, Aird WC, Kodama T, Minami T. Inoue K, et al. Among authors: yoshida m. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2652-9. doi: 10.1161/01.ATV.0000247247.89787.e7. Epub 2006 Sep 28. Arterioscler Thromb Vasc Biol. 2006. PMID: 17008592

9

Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.

Shinji C, Maeda S, Imai K, Yoshida M, Hashimoto Y, Miyachi H. Shinji C, et al. Among authors: yoshida m. Bioorg Med Chem. 2006 Nov 15;14(22):7625-51. doi: 10.1016/j.bmc.2006.07.008. Epub 2006 Jul 31. Bioorg Med Chem. 2006. PMID: 16877001

10

Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand.

Nishino N, Yoshikawa D, Watanabe LA, Kato T, Jose B, Komatsu Y, Sumida Y, Yoshida M. Nishino N, et al. Among authors: yoshida m. Bioorg Med Chem Lett. 2004 May 17;14(10):2427-31. doi: 10.1016/j.bmcl.2004.03.018. Bioorg Med Chem Lett. 2004. PMID: 15109626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results